Abstract
BackgroundTraditional and novel risk factors cannot sufficiently explain the differential susceptibility to cardiovascular disease (CVD). Epigenetics may serve to partially explain this residual disparity, with life course stressors shown to modify methylation of genes implicated in various diseases. Subclinical CVD is often comorbid with cognitive impairment (CI), which warrants research into the identification of common genes for both conditions.MethodsWe conducted a systematic review of the existing literature to identify studies depicting the relationship between life course stressors, DNA methylation, subclinical CVD, and cognition.ResultsA total of 16 articles (8 human and 8 animal) were identified, with the earliest published in 2008. Four genes (COMT, NOS3, Igfl1, and Sod2) were analyzed by more than one study, but not in association with both CVD and CI. One gene (NR3C1) was associated with both outcomes, albeit not within the same study. There was some consistency among studies with markers used for subclinical CVD and cognition, but considerable variability in stress exposure (especially in human studies), cell type/tissue of interest, method for detection of DNA methylation, and risk factors. Racial and ethnic differences were not considered, but analysis of sex in one human study found statistically significant differentially methylated X-linked loci associated with attention and intelligence.ConclusionsThis review suggests the need for additional studies to implement more comprehensive and methodologically rigorous study designs that can better identify epigenetic biomarkers to differentiate individuals vulnerable to both subclinical CVD and associated CI.
Highlights
Traditional and novel risk factors cannot sufficiently explain the differential susceptibility to cardiovascular disease (CVD)
Epidemiologic studies suggest a strong association between CVD and type 2 diabetes mellitus (T2DM), the latter of which affects over 25 million Americans [2]
Efforts aimed at identifying commonalities between subclinical CVD and cognition may serve as one approach to prevent clinical diagnosis of CVD and cognitive decline, which is especially prevalent in individuals with T2DM
Summary
Traditional and novel risk factors cannot sufficiently explain the differential susceptibility to cardiovascular disease (CVD). Subclinical CVD is often comorbid with cognitive impairment (CI), which warrants research into the identification of common genes for both conditions. Epidemiologic studies suggest a strong association between CVD and type 2 diabetes mellitus (T2DM), the latter of which affects over 25 million Americans [2]. Efforts aimed at identifying commonalities between subclinical CVD and cognition may serve as one approach to prevent clinical diagnosis of CVD and cognitive decline, which is especially prevalent in individuals with T2DM. Several traditional and novel risk factors have been reported for CVD. Novel risk factors for CVD include increased levels of inflammatory markers such as C-reactive protein and interleukin-6 [13]. There is still much variability, warranting research into the mechanisms that can explain residual disparity among individuals
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
